STING1 and neoplasm: With the development of nanotechnology, stimuli-responsive nanoplatforms designed based on tumor microenvironment (TME) signals (such as pH, glutathione, reactive oxygen species, hypoxia, and enzymes) and exogenous stimuli (including light, ultrasound, radiation, and magnetic fields) provide a promising strategy for the precise activation of the STING pathway.